Carbidopa and Levodopa Extended-Release Tablets and Semaglutide Subcutaneous
Determining the interaction of Carbidopa and Levodopa Extended-Release Tablets and Semaglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: semaglutide
Brand name: Ozempic, Rybelsus
Synonyms: Semaglutide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Extended-Release Tablets-Semaglutide Tablets
- Carbidopa and Levodopa Extended-Release Tablets-Semprex-D
- Carbidopa and Levodopa Extended-Release Tablets-Semprex-D Oral
- Carbidopa and Levodopa Extended-Release Tablets-Senatec Topical application
- Carbidopa and Levodopa Extended-Release Tablets-Senexon
- Carbidopa and Levodopa Extended-Release Tablets-Senexon-S
- Semaglutide Subcutaneous-Carbidopa and Levodopa ODT
- Semaglutide Subcutaneous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Semaglutide Subcutaneous-Carbidopa and levodopa Route Not Applicable
- Semaglutide Subcutaneous-Carbidopa and Levodopa Tablets
- Semaglutide Subcutaneous-Carbidopa Tablets
- Semaglutide Subcutaneous-Carbidopa, entacapone, and levodopa